CrushSCI.com
208.4Average days
191Median days
72Fastest days
391Longest days
6622025 publications

Paper Review Records

All Paper Review Records

21 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

152 days

Atypical clinicopathological features are associated with worse outcomes in anti-HMGCR myopathy

Authors
Hongxia Yang; Chao Sun; Xiaolan Tian; Wei Jiang; Wenli Li; Qingyan Liu; Qinglin Peng; Guochun Wang; Xin LuShow moreShow less
Affiliations
1. Department of Rheumatology, China-Japan Friendship Hospital & Beijing Key Laboratory of Precision Diagnosis, Treatment and Innovative Translation in Inflammatory Myopathies, Beijing, People’s Republic Of China; 2. Department of Clinical Laboratory, Peking University First Hospital, Beijing, People’s Republic of ChinaShow moreShow less
Source PDF DOI Publisher page
191 days

Genetic spectrum of GLA variants in Fabry Disease in Northern China

Authors
Yanling Zhang; Xinyu Zhang; Yilin Pan; Yijie Luo; Qian Wang; Qing Ye; Yan Liu; Zongwei Lin; Guihua Yao; Mei Dong; Xiaoping Ji; Huixia LuShow moreShow less
Affiliations
1. State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research, Department of Cardiology, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Qilu Hospital of Shandong University, Jinan, China; 2. Department of Radiology, Qilu Hospital of Shandong University, Jinan, China; 3. Department of Cardiology, Qilu Third Hospital of Shandong University, Qingdao, ChinaShow moreShow less
Source PDF DOI Publisher page
391 days

Exploring the landscape of clinical research in AATD: a cross-sectional review of registered studies in clinicaltrials.gov, clinicaltrialsregister.eu, and WHO ICTRP

Authors
Philipp Höger; Markus Ries; Arturo Olivares Rivera; Katharina Buschulte; Konstantina Kontogianni; Hilal Ersöz; Ralf Eberhardt; Sebastian Fähndrich; Sabina Janciauskiene; Felix Herth; Franziska C TrudzinskiShow moreShow less
Affiliations
1. Department of Pneumology and Critical Care Medicine, Thoraxklinik University of Heidelberg, Heidelberg, Germany; 2. Translational Lung Research Center (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany; 3. Medical Faculty Heidelberg, Center for Pediatrics and Adolescent Medicine, Pediatric Neurology and Metabolic Medicine, Heidelberg University, Heidelberg, Germany; 4. Department of Pneumology and Critical Care Medicine, Asklepios Klinik Barmbek, Hamburg, Germany; 5. Department of Pulmonology, Medical Faculty, University Medical Center Freiburg, Freiburg, Germany; 6. Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany; 7. Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research (DZL), Hannover, GermanyShow moreShow less
Source PDF DOI Publisher page
192 days

Qualitative insights from partners of individuals with Huntington’s disease: the quality of life of an under-researched population

Authors
Isobel Spray; Jeanette Thorpe; Ellie Johnstone; Wiebke Hannemann; Ferdinando Squitieri; Giulia Giancaterino; Paola Emilia Mina; Barbara D’Alessio; Astri Arnesen; Jiri Klempir; Olga Ulmanová; Pearl van Lonkhuizen; Anne-Wil Heemskerk; Jennifer Hoblyn; Emer O’Malley; Ramona Moldovan; Georg Bernhard Landwehrmeyer; Stephen Patrick McKenna; Alzbeta MuehlbaeckShow moreShow less
Affiliations
1. Galen Research, Manchester, UK; 2. Department of Neurology, University Hospital Ulm, Ulm, Germany; 3. Unità Huntington e Malattie Rare Fondazione IRCCS Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy; 4. Qrare Medical Centre, Fondazione Lega Italiana Ricerca Huntington (LIRH), Rome, Italy; 5. European Huntington Association, Kristiansand, Norway; 6. Department of Neurology, Centre of Clinical Neuroscience, First Faculty of Medicine, General University Hospital, Charles University, Prague, Czechia; 7. Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, Netherlands; 8. National eHealth Living Lab, Leiden University Medical Center, Leiden, Netherlands; 9. Huntington Center Topaz Overduin, Katwijk, Netherlands; 10. Trinity College Dublin, Dublin, Ireland; 11. St. John of God University Hospital, Dublin, Ireland; 12. Division of Evolution, Infection and Genomics, School of Biological Sciences, University of Manchester, Manchester, UK; 13. Manchester Centre for Genomic Medicine, St. Mary’s Hospital, Manchester University NHS Foundation Trust, Manchester, UK; 14. Department of Psychology, Babeș-Bolyai University, Cluj-Napoca, Romania; 15. Huntington Center South, Isar-Amper-Klinikum, Taufkirchen, GermanyShow moreShow less
Source PDF DOI Publisher page
234 days

Glycerol phenylbutyrate as an effective chemical chaperone for traffic-defective ABCB4 variants: comparative analysis with 4-phenylbutyrate

Authors
Manon Banet; Yosra Riahi; Emmanuel Gonzales; Emmanuel Jacquemin; Martine Lapalus; Thomas FalguièresShow moreShow less
Affiliations
1. Université Paris-Saclay, Inserm, Physiopathogénèse et traitement des maladies du foie, UMR_S 1193, Orsay, France; 2. Université Paris-Saclay, Faculté de Médecine, AP-HP, Bicêtre Hospital, Paediatric Hepatology & Paediatric Liver Transplant Department, Reference Center for Rare Paediatric Liver Diseases, FILFOIE, ERN RARE LIVER, Le Kremlin-Bicêtre, FranceShow moreShow less
Source PDF DOI Publisher page
118 days

Rapamycin rescues neuronal hyperexcitability and seizures driven by megalencephaly-causing AKT3 activation

Authors
Yosuke Miyamoto; Takuma Mori; Mitsuru Ishikawa; Eisuke Ichise; Yasuyo Suzuki; Yuko Furukawa; Amane Matsuura; Satoshi Yamashita; Takenori Tozawa; Tatsuji Hasegawa; Masafumi Morimoto; Tomoko Iehara; Hideyuki Okano; Shin Hayashi; Tomohiro ChiyonobuShow moreShow less
Affiliations
1. Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan; 2. Department of Genetics, Institute for Developmental Research, Aichi Developmental Disability Center, Kasugai, Japan; 3. Division of CNS Regeneration and Drug Discovery, International Center for Brain Science, Fujita Health University, Toyoake, Japan; 4. Keio University Regenerative Medicine Research Center, Kawasaki, Japan; 5. Department of Medical Science, School of Nursing, Kyoto Prefectural University of Medicine, Kyoto, Japan; 6. Department of Molecular Diagnostics and Therapeutics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, JapanShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Orphanet Journal of Rare Diseases take to review a manuscript?

As of 2026-11-18, CrushSCI has 21 complete review records for Orphanet Journal of Rare Diseases. The fastest paper went from submission to acceptance in 72 days (Defining the therapeutic corridor of stability in enzyme replacement therapy for Pompe disease: a position statement, received 2026-05-11, accepted 2026-07-22); the slowest took 391 days. The average is 208.4 days and the median is 191 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.